These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Influence of early season moxidectin treatments on acquisition of immunity to Ostertagia ostertagi in calves.
    Author: Satrija F, Nansen P, Midtgaard N, Yang X.
    Journal: Acta Vet Scand; 1995; 36(3):383-6. PubMed ID: 7502955.
    Abstract:
    Moxidectin, a newly developed endectocide, has previously been demonstrated to have a high efficacy against gastrointestinal nematodes in cattle (Ranjan et al. 1992, Scholl et al. 1992). In a field trial (Yang, Satrija and Nansen, unpublished data) matched groups of 8 first-season Black Pied Friesian heifer calves, 6-8 months of age, were turned out in early May 1992 on a permanent pasture contaminated with trichostrongyles. The groups were grazed separately on comparable plots until they were housed in mid October 1992. Group Β was treated with moxidectin at turnout, and group C was treated at turnout and again 8 weeks after turnout. A third group served as non-treated controls (group A). The results showed that the 2 early season prophylactic treatments (group C) reduced the late season herbage trichostrongyle larval infectivity with 80 to 90%, whereas the reduction accomplished by only 1 treatment at turnout (group B) was much less. Group C excreted significantly lower numbers of strongyle eggs than groups A and B. The non-treated controls showed clinical signs of trichostrongylosis in late September, which coincided with a steep rise in serum pepsinogen levels reaching an average peak level of 3.5 IU tyrosine litre-1. A few animals in group Β showed softening of faeces particularly in the very late season. In contrast, animals receiving 2 moxidectin treatments remained in a clinically good condition throughout the season.
    [Abstract] [Full Text] [Related] [New Search]